The hazard of death was also lower among patients receiving HER2-targeted therapy alone, although this did not reach statistical significance (HRs 0.47; 95% CI 0.17–1.34; p = 0.159).
← all excerpts
A Five-Year Single-Center Retrospective Study of Neoadjuvant Therapy Response and Survival in Romanian Women with Breast Cancer.
2
0.1590
0.1590
The sentences
Mortality rate of breast cancer in Romania has an increasing trend and is higher compared to other EU countries [ 63 ].